Pathstone Holdings’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-17,346
Closed -$221K 2412
2025
Q3
$221K Sell
17,346
-10,416
-38% -$151K ﹤0.01% 2163
2025
Q2
$441K Buy
+27,762
New +$415K ﹤0.01% 1776
2025
Q1
Sell
-25,852
Closed -$491K 2394
2024
Q4
$491K Buy
25,852
+18,408
+247% +$389K ﹤0.01% 1727
2024
Q3
$202K Sell
7,444
-2,014
-21% -$51.4K ﹤0.01% 2170
2024
Q2
$236K Sell
9,458
-7,620
-45% -$219K ﹤0.01% 2063
2024
Q1
$567K Buy
17,078
+1,132
+7% +$38.7K ﹤0.01% 1626
2023
Q4
$568K Buy
+15,946
New +$506K ﹤0.01% 1423

Other funds holding XRAY

Pathstone Holdings's XRAY Position: Q4 2025 in Review

Pathstone Holdings sold out of Dentsply Sirona (XRAY) in Q4 2025, closing a stake of 17,346 shares — an estimated $221K sold.

Pathstone Holdings first reported a position in XRAY in Q4 2023 and held it in 7 quarters. The position peaked at $568K in Q4 2023. 362 funds tracked by Wall St. Rank hold XRAY as of Q4 2025.

  • Pathstone Holdings reported no remaining Dentsply Sirona position as of Q4 2025 after selling out during the quarter.
  • Pathstone Holdings sold 17,346 Dentsply Sirona shares in Q4 2025, an estimated $221K.
  • Pathstone Holdings first reported a position in Dentsply Sirona in Q4 2023 and held it in 7 quarters.
  • Pathstone Holdings's Dentsply Sirona position peaked at $568K in Q4 2023.
  • 362 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2025.

Based on Pathstone Holdings's 13F filing for Q4 2025, filed 13 Feb 2026.